Sotera Health Company $SHC Shares Sold by Moore Capital Management LP

Moore Capital Management LP reduced its stake in Sotera Health Company (NASDAQ:SHC) by 15.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 213,946 shares of the company’s stock after selling 38,495 shares during the quarter. Moore Capital Management LP’s holdings in Sotera Health were worth $3,798,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. IFP Advisors Inc grew its holdings in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC purchased a new position in Sotera Health during the fourth quarter worth about $27,000. Meeder Asset Management Inc. purchased a new position in Sotera Health during the second quarter worth about $37,000. Root Financial Partners LLC boosted its holdings in Sotera Health by 217.5% in the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after purchasing an additional 1,455 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new position in Sotera Health in the 4th quarter valued at about $40,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SHC has been the subject of a number of recent analyst reports. Citigroup raised their price target on shares of Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Piper Sandler reiterated an “overweight” rating and issued a $25.00 price objective (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. JPMorgan Chase & Co. increased their price objective on Sotera Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Weiss Ratings raised Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Finally, The Goldman Sachs Group initiated coverage on Sotera Health in a research note on Friday, June 5th. They issued a “buy” rating and a $20.00 price target on the stock. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $21.50.

Insider Buying and Selling

In other news, insider Michael P. Rutz sold 150,000 shares of Sotera Health stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. The trade was a 30.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the business’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares of the company’s stock, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 1,294,515 shares of company stock valued at $23,999,528 in the last quarter. 15.36% of the stock is owned by insiders.

Sotera Health Price Performance

Sotera Health stock opened at $18.90 on Tuesday. The firm has a market cap of $5.39 billion, a PE ratio of 33.16 and a beta of 1.77. Sotera Health Company has a 52-week low of $13.09 and a 52-week high of $19.85. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. The company’s 50 day moving average is $18.18 and its two-hundred day moving average is $16.41.

Sotera Health (NASDAQ:SHC) last released its earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The firm had revenue of $321.38 million during the quarter, compared to analysts’ expectations of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.Sotera Health’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, research analysts expect that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.